Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression.

This publication has 13 references indexed in Scilit:

• Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.
  The Journal of Experimental Medicine, 1987
• Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved.
  Proceedings of the National Academy of Sciences, 1986
• Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
  Nature, 1986
• Antiviral effects of recombinant tumour necrosis factor in vitro
  Nature, 1986
• Variable expression of major histocompatibility antigens: Role in transplantation immunology
  Kidney International, 1986
• Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation
  Cell, 1986
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
  Nature, 1986
• Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.
  Proceedings of the National Academy of Sciences, 1986
• Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells.
  The EMBO Journal, 1984
• Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity
  Nature, 1983